Publications (24) Publications de FRANCISCO JAVIER SANZ FUENTENEBRO

2023

  1. Real-life outcomes in biotypes of psychotic disorders based on neurocognitive performance

    European Archives of Psychiatry and Clinical Neuroscience, Vol. 273, Núm. 6, pp. 1379-1386

2022

  1. Relation between EEG resting-state power and modulation of P300 task-related activity in theta band in schizophrenia

    Progress in Neuro-Psychopharmacology and Biological Psychiatry, Vol. 116

2021

  1. Neurobiological underpinnings of cognitive subtypes in psychoses: A cross-diagnostic cluster analysis

    Schizophrenia Research, Vol. 229, pp. 102-111

2020

  1. Deficits of entropy modulation of the EEG: A biomarker for altered function in schizophrenia and bipolar disorder?

    Journal of Psychiatry and Neuroscience, Vol. 45, Núm. 5, pp. 322-333

2019

  1. Pattern of use of clozapine in Spain. Variability and under-prescription

    Revista de Psiquiatria y Salud Mental, Vol. 12, Núm. 3, pp. 151-162

2018

  1. Stimulus characteristics in electroconvulsive therapy. A pragmatic review

    Revista de Psiquiatria y Salud Mental

2017

  1. Patrón de uso de la terapia electroconvulsiva en España: propuestas para una práctica óptima y un acceso equitativo

    Revista de Psiquiatria y Salud Mental, Vol. 10, Núm. 2, pp. 87-95

2016

  1. Electroconvulsive therapy practice in Spain: A national survey

    Journal of ECT, Vol. 32, Núm. 1, pp. 55-61

2015

  1. Quo Vadis clozapine? A bibliometric study of 45 years of research in international context

    International Journal of Molecular Sciences, Vol. 16, Núm. 9, pp. 23012-23034

2014

  1. Greater clinical and cognitive improvement with clozapine and risperidone associated with a thinner cortex at baseline in first-episode schizophrenia

    Schizophrenia Research, Vol. 158, Núm. 1-3, pp. 223-229

2013

  1. Randomized trial of clozapine vs. risperidone in treatment-naïve first-episode schizophrenia: Results after one year

    Schizophrenia Research, Vol. 149, Núm. 1-3, pp. 156-161

2012

  1. Clozapine as treatment of first choice in first psychotic episodes. What do we know?

    Actas Espanolas de Psiquiatria, Vol. 40, Núm. 5, pp. 281-289

  2. Monitorización de niveles plasma de antipsicóticos atípicos

    Revista de la Asociación Española de Neuropsiquiatría, Vol. 32, Núm. 115, pp. 499-519

2011

  1. Effectiveness and risks of combining antipsychotic drugs with electroconvulsive treatment

    Revista de Psiquiatria y Salud Mental

  2. Electroconvulsive therapy as treatment for malignant neuroleptic syndrome

    Revista de Psiquiatria y Salud Mental

2008

  1. A 12-month, open-label, comparative study of quetiapine and risperidone in the acute and long-term treatment of schizophrenia

    International Clinical Psychopharmacology, Vol. 23, Núm. 3, pp. 138-149

2006

  1. Cuestionarios de satisfacción en psiquiatría: Ventajas y controversias

    Revista de la Asociación Española de Neuropsiquiatría, Vol. 26, Núm. 98, pp. 289-301

2001

  1. Esquizofrenia "resistente". Conceptos confusos y tratamientos esperanzadores

    Psiquiatría biológica: Publicación oficial de la Sociedad Española de Psiquiatría Biológica, Vol. 8, Núm. 1, pp. 11-18

  2. Postictal Psychosis: Resolution after Electroconvulsive Therapy

    Epilepsy and Behavior, Vol. 2, Núm. 4, pp. 363-366

1996

  1. Family psychoeducational support groups in spain: Parents' distress and burden at nine-month follow-up

    Annals of Clinical Psychiatry, Vol. 8, Núm. 2, pp. 71-79